Tandem Diabetes Care (TNDM)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 06-2022 | 03-2022 | 12-2021 | 09-2021 | 06-2021 | |
| Assets | |||||
| Current Assets | |||||
| Cash & Cash Equivalents | 114,966 | 93,681 | 71,181 | 112,375 | 98,578 |
| Marketable Securities | 520,365 | 541,710 | 552,630 | 482,618 | 446,724 |
| Receivables | 103,763 | 94,133 | 110,725 | 87,462 | 80,212 |
| Inventories | 88,098 | 79,987 | 68,551 | 65,734 | 66,705 |
| TOTAL | $835,044 | $818,464 | $811,520 | $754,947 | $698,285 |
| Non-Current Assets | |||||
| PPE Net | 58,901 | 49,987 | 50,386 | 49,621 | 48,890 |
| Other Non-Current Assets | 142,630 | 146,826 | 43,231 | 45,711 | 48,075 |
| TOTAL | $201,531 | $196,813 | $93,617 | $95,332 | $96,965 |
| Total Assets | $1,036,575 | $1,015,277 | $905,137 | $850,279 | $795,250 |
| Liabilities | |||||
| Current Liabilities | |||||
| Accounts payable and accrued liabilities | 50,661 | 45,341 | 28,032 | 26,973 | 27,504 |
| Accrued Expenses | 7,610 | 6,362 | 9,419 | 6,330 | 6,405 |
| Other current liabilities | 23,921 | 22,893 | 23,388 | 20,845 | 21,125 |
| TOTAL | $139,259 | $131,815 | $131,856 | $119,650 | $108,723 |
| Non-Current Liabilities | |||||
| Deferred Revenues | 11,713 | 10,881 | 10,182 | 9,022 | 7,953 |
| Other Non-Current Liabilities | 429,389 | 428,549 | 323,229 | 340,975 | 340,442 |
| TOTAL | $447,732 | $446,080 | $340,169 | $340,975 | $340,442 |
| Total Liabilities | $586,991 | $577,895 | $472,025 | $460,625 | $449,165 |
| Shareholders' Equity | |||||
| Shares Outstanding, K | 64,221 | 63,963 | 63,872 | 63,533 | 63,029 |
| Common Shares | 64 | 64 | 64 | 63 | 63 |
| Retained earnings | -664,366 | -649,310 | -634,595 | -645,403 | -651,197 |
| Other shareholders' equity | -4,282 | -3,061 | -616 | 14 | 29 |
| TOTAL | $449,584 | $437,382 | $433,112 | $389,654 | $346,085 |
| Total Liabilities And Equity | $1,036,575 | $1,015,277 | $905,137 | $850,279 | $795,250 |